Company intelligence / Profile preview

Milarex

Ownership: Private
Employees: ~1535
Development stage: Commercial

Overview

Milarex is one of the world’s largest value-added salmon processors, producing over 65 million consumer products annually. The company focuses on safe and sustainable salmon products for global retail and food service markets. It operates a state-of-the-art production facility in Poland with rigorous quality control and traceability systems. There are no clinical results as it is not a healthcare or biotech company.

Industry: Food & Nutrition

Partnerships

Not specified; focus on relationships with sustainable raw material suppliers

Beyond the preview

Go deeper on Milarex.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Milarex.

Explore the full profile